nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP2D6—Fingolimod—multiple sclerosis	0.0675	0.121	CbGbCtD
Temsirolimus—ABCB1—Methylprednisolone—multiple sclerosis	0.0461	0.083	CbGbCtD
Temsirolimus—CYP3A4—Fingolimod—multiple sclerosis	0.0429	0.0772	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0357	0.0643	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—multiple sclerosis	0.0357	0.0643	CbGbCtD
Temsirolimus—ABCB1—Mitoxantrone—multiple sclerosis	0.0337	0.0606	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—multiple sclerosis	0.03	0.054	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—multiple sclerosis	0.0296	0.0533	CbGbCtD
Temsirolimus—ABCB1—Prednisone—multiple sclerosis	0.0279	0.0503	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—multiple sclerosis	0.0276	0.0498	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—multiple sclerosis	0.0268	0.0483	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—multiple sclerosis	0.0209	0.0377	CbGbCtD
Temsirolimus—CYP3A4—Mitoxantrone—multiple sclerosis	0.0202	0.0363	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—multiple sclerosis	0.018	0.0324	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—multiple sclerosis	0.0177	0.0319	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—multiple sclerosis	0.0174	0.0314	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—multiple sclerosis	0.0167	0.0301	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—multiple sclerosis	0.0164	0.0296	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—multiple sclerosis	0.014	0.0252	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—multiple sclerosis	0.0105	0.0188	CbGbCtD
Temsirolimus—MTOR—leg—multiple sclerosis	0.00773	0.28	CbGeAlD
Temsirolimus—MTOR—brainstem—multiple sclerosis	0.0018	0.0653	CbGeAlD
Temsirolimus—MTOR—retina—multiple sclerosis	0.00174	0.063	CbGeAlD
Temsirolimus—FKBP1A—retina—multiple sclerosis	0.00156	0.0567	CbGeAlD
Temsirolimus—FKBP1A—medulla oblongata—multiple sclerosis	0.00113	0.041	CbGeAlD
Temsirolimus—MTOR—spinal cord—multiple sclerosis	0.00112	0.0406	CbGeAlD
Temsirolimus—FKBP1A—midbrain—multiple sclerosis	0.00103	0.0374	CbGeAlD
Temsirolimus—FKBP1A—spinal cord—multiple sclerosis	0.00101	0.0365	CbGeAlD
Temsirolimus—MTOR—nervous system—multiple sclerosis	0.000944	0.0342	CbGeAlD
Temsirolimus—MTOR—central nervous system—multiple sclerosis	0.000909	0.0329	CbGeAlD
Temsirolimus—MTOR—cerebellum—multiple sclerosis	0.000889	0.0322	CbGeAlD
Temsirolimus—FKBP1A—nervous system—multiple sclerosis	0.000849	0.0308	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—multiple sclerosis	0.000818	0.0296	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—multiple sclerosis	0.000799	0.029	CbGeAlD
Temsirolimus—MTOR—brain—multiple sclerosis	0.000722	0.0262	CbGeAlD
Temsirolimus—FKBP1A—brain—multiple sclerosis	0.000649	0.0235	CbGeAlD
Temsirolimus—CYP2D6—brainstem—multiple sclerosis	0.000521	0.0189	CbGeAlD
Temsirolimus—ABCB1—retina—multiple sclerosis	0.000362	0.0131	CbGeAlD
Temsirolimus—CYP3A4—nervous system—multiple sclerosis	0.000278	0.0101	CbGeAlD
Temsirolimus—CYP2D6—nervous system—multiple sclerosis	0.000273	0.0099	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—multiple sclerosis	0.000267	0.00968	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—multiple sclerosis	0.000263	0.00953	CbGeAlD
Temsirolimus—ABCB1—medulla oblongata—multiple sclerosis	0.000261	0.00948	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—multiple sclerosis	0.000257	0.00931	CbGeAlD
Temsirolimus—ABCB1—midbrain—multiple sclerosis	0.000239	0.00866	CbGeAlD
Temsirolimus—ABCB1—spinal cord—multiple sclerosis	0.000233	0.00845	CbGeAlD
Temsirolimus—CYP2D6—brain—multiple sclerosis	0.000209	0.00757	CbGeAlD
Temsirolimus—Back pain—Triamcinolone—multiple sclerosis	0.000208	0.000729	CcSEcCtD
Temsirolimus—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000207	0.000727	CcSEcCtD
Temsirolimus—Somnolence—Mitoxantrone—multiple sclerosis	0.000206	0.000725	CcSEcCtD
Temsirolimus—Angiopathy—Dexamethasone—multiple sclerosis	0.000203	0.000713	CcSEcCtD
Temsirolimus—Angiopathy—Betamethasone—multiple sclerosis	0.000203	0.000713	CcSEcCtD
Temsirolimus—Convulsion—Prednisolone—multiple sclerosis	0.000202	0.00071	CcSEcCtD
Temsirolimus—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000202	0.000709	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—multiple sclerosis	0.000201	0.000708	CcSEcCtD
Temsirolimus—Fatigue—Mitoxantrone—multiple sclerosis	0.0002	0.000703	CcSEcCtD
Temsirolimus—Constipation—Mitoxantrone—multiple sclerosis	0.000198	0.000697	CcSEcCtD
Temsirolimus—Pain—Mitoxantrone—multiple sclerosis	0.000198	0.000697	CcSEcCtD
Temsirolimus—ABCB1—nervous system—multiple sclerosis	0.000196	0.00712	CbGeAlD
Temsirolimus—Diarrhoea—Azathioprine—multiple sclerosis	0.000196	0.00069	CcSEcCtD
Temsirolimus—Angioedema—Triamcinolone—multiple sclerosis	0.000196	0.000689	CcSEcCtD
Temsirolimus—Angioedema—Methylprednisolone—multiple sclerosis	0.000196	0.000687	CcSEcCtD
Temsirolimus—Erythema—Dexamethasone—multiple sclerosis	0.000195	0.000684	CcSEcCtD
Temsirolimus—Erythema—Betamethasone—multiple sclerosis	0.000195	0.000684	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—multiple sclerosis	0.000191	0.000672	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00019	0.000669	CcSEcCtD
Temsirolimus—Oedema—Prednisolone—multiple sclerosis	0.00019	0.000669	CcSEcCtD
Temsirolimus—Dysuria—Methotrexate—multiple sclerosis	0.00019	0.000668	CcSEcCtD
Temsirolimus—Neutropenia—Methotrexate—multiple sclerosis	0.00019	0.000668	CcSEcCtD
Temsirolimus—Dizziness—Azathioprine—multiple sclerosis	0.00019	0.000667	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00019	0.000667	CcSEcCtD
Temsirolimus—ABCB1—central nervous system—multiple sclerosis	0.000189	0.00685	CbGeAlD
Temsirolimus—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000189	0.000664	CcSEcCtD
Temsirolimus—Cough—Triamcinolone—multiple sclerosis	0.000187	0.000658	CcSEcCtD
Temsirolimus—Convulsion—Triamcinolone—multiple sclerosis	0.000186	0.000653	CcSEcCtD
Temsirolimus—Convulsion—Methylprednisolone—multiple sclerosis	0.000185	0.000652	CcSEcCtD
Temsirolimus—Hypertension—Triamcinolone—multiple sclerosis	0.000185	0.000651	CcSEcCtD
Temsirolimus—ABCB1—cerebellum—multiple sclerosis	0.000185	0.0067	CbGeAlD
Temsirolimus—Hypertension—Methylprednisolone—multiple sclerosis	0.000185	0.000649	CcSEcCtD
Temsirolimus—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000183	0.000645	CcSEcCtD
Temsirolimus—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000183	0.000645	CcSEcCtD
Temsirolimus—Myalgia—Triamcinolone—multiple sclerosis	0.000183	0.000642	CcSEcCtD
Temsirolimus—Vomiting—Azathioprine—multiple sclerosis	0.000183	0.000641	CcSEcCtD
Temsirolimus—Pneumonia—Methotrexate—multiple sclerosis	0.000182	0.000641	CcSEcCtD
Temsirolimus—Arthralgia—Methylprednisolone—multiple sclerosis	0.000182	0.00064	CcSEcCtD
Temsirolimus—Myalgia—Methylprednisolone—multiple sclerosis	0.000182	0.00064	CcSEcCtD
Temsirolimus—Eye disorder—Prednisone—multiple sclerosis	0.000182	0.00064	CcSEcCtD
Temsirolimus—Anxiety—Methylprednisolone—multiple sclerosis	0.000182	0.000638	CcSEcCtD
Temsirolimus—Infestation—Methotrexate—multiple sclerosis	0.000181	0.000637	CcSEcCtD
Temsirolimus—Infestation NOS—Methotrexate—multiple sclerosis	0.000181	0.000637	CcSEcCtD
Temsirolimus—Rash—Azathioprine—multiple sclerosis	0.000181	0.000636	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000181	0.000636	CcSEcCtD
Temsirolimus—Dermatitis—Azathioprine—multiple sclerosis	0.000181	0.000636	CcSEcCtD
Temsirolimus—Depression—Methotrexate—multiple sclerosis	0.000181	0.000635	CcSEcCtD
Temsirolimus—Headache—Azathioprine—multiple sclerosis	0.00018	0.000632	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00018	0.000632	CcSEcCtD
Temsirolimus—Renal failure—Methotrexate—multiple sclerosis	0.000178	0.000626	CcSEcCtD
Temsirolimus—Angioedema—Betamethasone—multiple sclerosis	0.000178	0.000625	CcSEcCtD
Temsirolimus—Angioedema—Dexamethasone—multiple sclerosis	0.000178	0.000625	CcSEcCtD
Temsirolimus—Stomatitis—Methotrexate—multiple sclerosis	0.000177	0.000621	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—multiple sclerosis	0.000177	0.000621	CcSEcCtD
Temsirolimus—Conjunctivitis—Methotrexate—multiple sclerosis	0.000176	0.000619	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—multiple sclerosis	0.000176	0.000618	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000175	0.000615	CcSEcCtD
Temsirolimus—Oedema—Triamcinolone—multiple sclerosis	0.000175	0.000615	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000175	0.000614	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—multiple sclerosis	0.000174	0.000611	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—multiple sclerosis	0.000174	0.00061	CcSEcCtD
Temsirolimus—Haematuria—Methotrexate—multiple sclerosis	0.000173	0.000607	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—multiple sclerosis	0.000172	0.000605	CcSEcCtD
Temsirolimus—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000171	0.000602	CcSEcCtD
Temsirolimus—Epistaxis—Methotrexate—multiple sclerosis	0.000171	0.000601	CcSEcCtD
Temsirolimus—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000171	0.000601	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—multiple sclerosis	0.000171	0.0006	CcSEcCtD
Temsirolimus—Nausea—Azathioprine—multiple sclerosis	0.000171	0.000599	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—multiple sclerosis	0.00017	0.000596	CcSEcCtD
Temsirolimus—Erythema—Prednisone—multiple sclerosis	0.00017	0.000596	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—multiple sclerosis	0.00017	0.000596	CcSEcCtD
Temsirolimus—Convulsion—Betamethasone—multiple sclerosis	0.000169	0.000593	CcSEcCtD
Temsirolimus—Convulsion—Dexamethasone—multiple sclerosis	0.000169	0.000593	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—multiple sclerosis	0.000168	0.000591	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—multiple sclerosis	0.000168	0.000591	CcSEcCtD
Temsirolimus—Asthenia—Mitoxantrone—multiple sclerosis	0.000167	0.000585	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—multiple sclerosis	0.000166	0.000582	CcSEcCtD
Temsirolimus—Myalgia—Dexamethasone—multiple sclerosis	0.000166	0.000582	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—multiple sclerosis	0.000165	0.00058	CcSEcCtD
Temsirolimus—Anxiety—Dexamethasone—multiple sclerosis	0.000165	0.00058	CcSEcCtD
Temsirolimus—Pain—Prednisolone—multiple sclerosis	0.000163	0.000572	CcSEcCtD
Temsirolimus—Pharyngitis—Methotrexate—multiple sclerosis	0.000162	0.000568	CcSEcCtD
Temsirolimus—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000161	0.000565	CcSEcCtD
Temsirolimus—Urethral disorder—Methotrexate—multiple sclerosis	0.00016	0.000561	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00016	0.000561	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000159	0.000559	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000159	0.000558	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—multiple sclerosis	0.000159	0.000558	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—multiple sclerosis	0.000159	0.000558	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000159	0.000558	CcSEcCtD
Temsirolimus—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000159	0.000558	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—multiple sclerosis	0.000158	0.000557	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—multiple sclerosis	0.000158	0.000555	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—multiple sclerosis	0.000158	0.000555	CcSEcCtD
Temsirolimus—Infection—Betamethasone—multiple sclerosis	0.000158	0.000555	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—multiple sclerosis	0.000157	0.000551	CcSEcCtD
Temsirolimus—Dyspnoea—Triamcinolone—multiple sclerosis	0.000156	0.000549	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000156	0.000548	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—multiple sclerosis	0.000156	0.000548	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000156	0.000547	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000156	0.000547	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—multiple sclerosis	0.000155	0.000544	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—multiple sclerosis	0.000154	0.000541	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—multiple sclerosis	0.000152	0.000534	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—multiple sclerosis	0.000151	0.000532	CcSEcCtD
Temsirolimus—Anorexia—Betamethasone—multiple sclerosis	0.000151	0.000532	CcSEcCtD
Temsirolimus—Cardiac disorder—Methotrexate—multiple sclerosis	0.000151	0.000531	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—multiple sclerosis	0.000151	0.00053	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—multiple sclerosis	0.000151	0.000529	CcSEcCtD
Temsirolimus—ABCB1—brain—multiple sclerosis	0.00015	0.00544	CbGeAlD
Temsirolimus—Pain—Triamcinolone—multiple sclerosis	0.00015	0.000526	CcSEcCtD
Temsirolimus—Angiopathy—Methotrexate—multiple sclerosis	0.000148	0.000519	CcSEcCtD
Temsirolimus—Vomiting—Mitoxantrone—multiple sclerosis	0.000148	0.000519	CcSEcCtD
Temsirolimus—Immune system disorder—Methotrexate—multiple sclerosis	0.000147	0.000517	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—multiple sclerosis	0.000147	0.000516	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000147	0.000515	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—multiple sclerosis	0.000146	0.000514	CcSEcCtD
Temsirolimus—Rash—Mitoxantrone—multiple sclerosis	0.000146	0.000514	CcSEcCtD
Temsirolimus—Dermatitis—Mitoxantrone—multiple sclerosis	0.000146	0.000514	CcSEcCtD
Temsirolimus—Chills—Methotrexate—multiple sclerosis	0.000146	0.000513	CcSEcCtD
Temsirolimus—Headache—Mitoxantrone—multiple sclerosis	0.000145	0.000511	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000145	0.000509	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000145	0.000509	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—multiple sclerosis	0.000144	0.000507	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—multiple sclerosis	0.000144	0.000507	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—multiple sclerosis	0.000144	0.000505	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—multiple sclerosis	0.000144	0.000505	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—multiple sclerosis	0.000144	0.000505	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000143	0.000504	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000143	0.000502	CcSEcCtD
Temsirolimus—Mental disorder—Methotrexate—multiple sclerosis	0.000143	0.000501	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—multiple sclerosis	0.000142	0.000498	CcSEcCtD
Temsirolimus—Erythema—Methotrexate—multiple sclerosis	0.000142	0.000498	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—multiple sclerosis	0.00014	0.000493	CcSEcCtD
Temsirolimus—Dysgeusia—Methotrexate—multiple sclerosis	0.000139	0.000488	CcSEcCtD
Temsirolimus—Body temperature increased—Triamcinolone—multiple sclerosis	0.000138	0.000486	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—multiple sclerosis	0.000138	0.000486	CcSEcCtD
Temsirolimus—Oedema—Prednisone—multiple sclerosis	0.000138	0.000486	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000138	0.000485	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—multiple sclerosis	0.000138	0.000485	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—multiple sclerosis	0.000138	0.000485	CcSEcCtD
Temsirolimus—Nausea—Mitoxantrone—multiple sclerosis	0.000138	0.000484	CcSEcCtD
Temsirolimus—Infection—Prednisone—multiple sclerosis	0.000137	0.000483	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000137	0.000482	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000137	0.000482	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—multiple sclerosis	0.000137	0.000482	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—multiple sclerosis	0.000137	0.000481	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—multiple sclerosis	0.000137	0.000481	CcSEcCtD
Temsirolimus—Pain—Dexamethasone—multiple sclerosis	0.000136	0.000477	CcSEcCtD
Temsirolimus—Pain—Betamethasone—multiple sclerosis	0.000136	0.000477	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—multiple sclerosis	0.000136	0.000477	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—multiple sclerosis	0.000134	0.000472	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—multiple sclerosis	0.000132	0.000463	CcSEcCtD
Temsirolimus—Anaemia—Methotrexate—multiple sclerosis	0.000131	0.00046	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00013	0.000457	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00013	0.000457	CcSEcCtD
Temsirolimus—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000129	0.000453	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000129	0.000452	CcSEcCtD
Temsirolimus—Leukopenia—Methotrexate—multiple sclerosis	0.000127	0.000446	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000126	0.000443	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—multiple sclerosis	0.000126	0.000442	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—multiple sclerosis	0.000126	0.000441	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—multiple sclerosis	0.000126	0.000441	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—multiple sclerosis	0.000126	0.000441	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—multiple sclerosis	0.000126	0.000441	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—multiple sclerosis	0.000126	0.000441	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—multiple sclerosis	0.000125	0.00044	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—multiple sclerosis	0.000125	0.00044	CcSEcCtD
Temsirolimus—Pruritus—Triamcinolone—multiple sclerosis	0.000124	0.000435	CcSEcCtD
Temsirolimus—Cough—Methotrexate—multiple sclerosis	0.000124	0.000434	CcSEcCtD
Temsirolimus—Pruritus—Methylprednisolone—multiple sclerosis	0.000124	0.000434	CcSEcCtD
Temsirolimus—Convulsion—Methotrexate—multiple sclerosis	0.000123	0.000431	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—multiple sclerosis	0.000121	0.000424	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—multiple sclerosis	0.000121	0.000424	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—multiple sclerosis	0.000121	0.000424	CcSEcCtD
Temsirolimus—Decreased appetite—Prednisone—multiple sclerosis	0.00012	0.000423	CcSEcCtD
Temsirolimus—Rash—Prednisolone—multiple sclerosis	0.00012	0.000422	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—multiple sclerosis	0.00012	0.000421	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00012	0.000421	CcSEcCtD
Temsirolimus—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00012	0.00042	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—multiple sclerosis	0.000119	0.000419	CcSEcCtD
Temsirolimus—Headache—Prednisolone—multiple sclerosis	0.000119	0.000419	CcSEcCtD
Temsirolimus—Constipation—Prednisone—multiple sclerosis	0.000118	0.000416	CcSEcCtD
Temsirolimus—Dizziness—Triamcinolone—multiple sclerosis	0.000116	0.000407	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000116	0.000406	CcSEcCtD
Temsirolimus—Dizziness—Methylprednisolone—multiple sclerosis	0.000116	0.000406	CcSEcCtD
Temsirolimus—Infection—Methotrexate—multiple sclerosis	0.000115	0.000404	CcSEcCtD
Temsirolimus—Asthenia—Dexamethasone—multiple sclerosis	0.000114	0.000401	CcSEcCtD
Temsirolimus—Asthenia—Betamethasone—multiple sclerosis	0.000114	0.000401	CcSEcCtD
Temsirolimus—Nervous system disorder—Methotrexate—multiple sclerosis	0.000113	0.000398	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000113	0.000398	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000113	0.000398	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—multiple sclerosis	0.000113	0.000397	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—multiple sclerosis	0.000112	0.000395	CcSEcCtD
Temsirolimus—Pruritus—Dexamethasone—multiple sclerosis	0.000112	0.000395	CcSEcCtD
Temsirolimus—Skin disorder—Methotrexate—multiple sclerosis	0.000112	0.000395	CcSEcCtD
Temsirolimus—Vomiting—Triamcinolone—multiple sclerosis	0.000111	0.000391	CcSEcCtD
Temsirolimus—Vomiting—Methylprednisolone—multiple sclerosis	0.000111	0.00039	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—multiple sclerosis	0.00011	0.000388	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—multiple sclerosis	0.00011	0.000388	CcSEcCtD
Temsirolimus—Anorexia—Methotrexate—multiple sclerosis	0.00011	0.000387	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—multiple sclerosis	0.00011	0.000387	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—multiple sclerosis	0.00011	0.000387	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—multiple sclerosis	0.00011	0.000385	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—multiple sclerosis	0.000109	0.000385	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—multiple sclerosis	0.000109	0.000384	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—multiple sclerosis	0.000109	0.000384	CcSEcCtD
Temsirolimus—Diarrhoea—Dexamethasone—multiple sclerosis	0.000109	0.000382	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—multiple sclerosis	0.000109	0.000382	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000105	0.00037	CcSEcCtD
Temsirolimus—Dizziness—Dexamethasone—multiple sclerosis	0.000105	0.000369	CcSEcCtD
Temsirolimus—Dizziness—Betamethasone—multiple sclerosis	0.000105	0.000369	CcSEcCtD
Temsirolimus—Insomnia—Methotrexate—multiple sclerosis	0.000105	0.000368	CcSEcCtD
Temsirolimus—Nausea—Triamcinolone—multiple sclerosis	0.000104	0.000365	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—multiple sclerosis	0.000104	0.000365	CcSEcCtD
Temsirolimus—Dyspnoea—Methotrexate—multiple sclerosis	0.000103	0.000362	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—multiple sclerosis	0.000103	0.000361	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisone—multiple sclerosis	0.000102	0.000358	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—multiple sclerosis	0.000101	0.000355	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—multiple sclerosis	0.000101	0.000355	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—multiple sclerosis	0.000101	0.000353	CcSEcCtD
Temsirolimus—Rash—Dexamethasone—multiple sclerosis	0.0001	0.000352	CcSEcCtD
Temsirolimus—Rash—Betamethasone—multiple sclerosis	0.0001	0.000352	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—multiple sclerosis	0.0001	0.000352	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—multiple sclerosis	0.0001	0.000352	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.98e-05	0.000351	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—multiple sclerosis	9.97e-05	0.00035	CcSEcCtD
Temsirolimus—Headache—Betamethasone—multiple sclerosis	9.95e-05	0.00035	CcSEcCtD
Temsirolimus—Headache—Dexamethasone—multiple sclerosis	9.95e-05	0.00035	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—multiple sclerosis	9.93e-05	0.000349	CcSEcCtD
Temsirolimus—Pain—Methotrexate—multiple sclerosis	9.89e-05	0.000347	CcSEcCtD
Temsirolimus—Pruritus—Prednisone—multiple sclerosis	9.79e-05	0.000344	CcSEcCtD
Temsirolimus—Diarrhoea—Prednisone—multiple sclerosis	9.47e-05	0.000333	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.46e-05	0.000332	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—multiple sclerosis	9.44e-05	0.000332	CcSEcCtD
Temsirolimus—Nausea—Betamethasone—multiple sclerosis	9.44e-05	0.000332	CcSEcCtD
Temsirolimus—Dizziness—Prednisone—multiple sclerosis	9.15e-05	0.000322	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—multiple sclerosis	9.14e-05	0.000321	CcSEcCtD
Temsirolimus—Body temperature increased—Methotrexate—multiple sclerosis	9.14e-05	0.000321	CcSEcCtD
Temsirolimus—Vomiting—Prednisone—multiple sclerosis	8.8e-05	0.000309	CcSEcCtD
Temsirolimus—Rash—Prednisone—multiple sclerosis	8.72e-05	0.000307	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—multiple sclerosis	8.72e-05	0.000306	CcSEcCtD
Temsirolimus—Headache—Prednisone—multiple sclerosis	8.67e-05	0.000305	CcSEcCtD
Temsirolimus—Hypersensitivity—Methotrexate—multiple sclerosis	8.52e-05	0.000299	CcSEcCtD
Temsirolimus—Asthenia—Methotrexate—multiple sclerosis	8.3e-05	0.000292	CcSEcCtD
Temsirolimus—Nausea—Prednisone—multiple sclerosis	8.22e-05	0.000289	CcSEcCtD
Temsirolimus—Pruritus—Methotrexate—multiple sclerosis	8.18e-05	0.000287	CcSEcCtD
Temsirolimus—Diarrhoea—Methotrexate—multiple sclerosis	7.91e-05	0.000278	CcSEcCtD
Temsirolimus—Dizziness—Methotrexate—multiple sclerosis	7.65e-05	0.000269	CcSEcCtD
Temsirolimus—MTOR—BDNF signaling pathway—MAPK1—multiple sclerosis	7.64e-05	0.000577	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—multiple sclerosis	7.56e-05	0.000571	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	7.52e-05	0.000568	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MX1—multiple sclerosis	7.51e-05	0.000568	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—multiple sclerosis	7.44e-05	0.000563	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—MAPK1—multiple sclerosis	7.43e-05	0.000562	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	7.36e-05	0.000556	CbGpPWpGaD
Temsirolimus—Vomiting—Methotrexate—multiple sclerosis	7.35e-05	0.000258	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—MAPK1—multiple sclerosis	7.32e-05	0.000553	CbGpPWpGaD
Temsirolimus—Rash—Methotrexate—multiple sclerosis	7.29e-05	0.000256	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—multiple sclerosis	7.28e-05	0.000256	CcSEcCtD
Temsirolimus—MTOR—Immune System—HLA-DRA—multiple sclerosis	7.27e-05	0.000549	CbGpPWpGaD
Temsirolimus—Headache—Methotrexate—multiple sclerosis	7.24e-05	0.000255	CcSEcCtD
Temsirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.22e-05	0.000546	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SRM—multiple sclerosis	7.21e-05	0.000545	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—STAT3—multiple sclerosis	7.13e-05	0.000539	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	7.03e-05	0.000531	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	7.03e-05	0.000531	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—multiple sclerosis	7.03e-05	0.000531	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—MAPK1—multiple sclerosis	7.02e-05	0.000531	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—S1PR1—multiple sclerosis	7e-05	0.000529	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—MAPK1—multiple sclerosis	6.99e-05	0.000528	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—multiple sclerosis	6.98e-05	0.000527	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.98e-05	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—STAT3—multiple sclerosis	6.97e-05	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—MAPK1—multiple sclerosis	6.95e-05	0.000526	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—MAPK1—multiple sclerosis	6.95e-05	0.000526	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.95e-05	0.000525	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—TYK2—multiple sclerosis	6.93e-05	0.000524	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—MAPK1—multiple sclerosis	6.92e-05	0.000523	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—MAPK1—multiple sclerosis	6.88e-05	0.00052	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.88e-05	0.00052	CbGpPWpGaD
Temsirolimus—Nausea—Methotrexate—multiple sclerosis	6.87e-05	0.000241	CcSEcCtD
Temsirolimus—MTOR—Adaptive Immune System—VCAM1—multiple sclerosis	6.86e-05	0.000519	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NOD1—multiple sclerosis	6.85e-05	0.000518	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQA1—multiple sclerosis	6.84e-05	0.000517	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GPC5—multiple sclerosis	6.81e-05	0.000515	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.69e-05	0.000505	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.68e-05	0.000505	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MALT1—multiple sclerosis	6.62e-05	0.0005	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL3—multiple sclerosis	6.54e-05	0.000494	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRF5—multiple sclerosis	6.51e-05	0.000492	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MAPK1—multiple sclerosis	6.48e-05	0.00049	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—MAPK1—multiple sclerosis	6.48e-05	0.00049	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—MAPK1—multiple sclerosis	6.48e-05	0.00049	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GPC5—multiple sclerosis	6.43e-05	0.000486	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD86—multiple sclerosis	6.42e-05	0.000485	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—MAPK1—multiple sclerosis	6.42e-05	0.000485	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQB1—multiple sclerosis	6.4e-05	0.000484	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	6.36e-05	0.000481	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—MAPK1—multiple sclerosis	6.33e-05	0.000479	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RPL5—multiple sclerosis	6.33e-05	0.000478	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	6.31e-05	0.000477	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTGER4—multiple sclerosis	6.3e-05	0.000476	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFIH1—multiple sclerosis	6.22e-05	0.00047	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRF8—multiple sclerosis	6.22e-05	0.00047	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-G—multiple sclerosis	6.22e-05	0.00047	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PGR—multiple sclerosis	6.2e-05	0.000469	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD86—multiple sclerosis	6.17e-05	0.000466	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD86—multiple sclerosis	6.14e-05	0.000464	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR3—multiple sclerosis	6.08e-05	0.00046	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC11A1—multiple sclerosis	6.06e-05	0.000458	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—multiple sclerosis	6.05e-05	0.000457	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD28—multiple sclerosis	6.03e-05	0.000455	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HLA-B—multiple sclerosis	5.99e-05	0.000453	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—multiple sclerosis	5.98e-05	0.000452	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—multiple sclerosis	5.97e-05	0.000451	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RGS1—multiple sclerosis	5.96e-05	0.00045	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR2—multiple sclerosis	5.92e-05	0.000447	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.88e-05	0.000445	CbGpPWpGaD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.85e-05	0.000442	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TNFAIP3—multiple sclerosis	5.83e-05	0.00044	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-B—multiple sclerosis	5.75e-05	0.000435	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	5.74e-05	0.000434	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—multiple sclerosis	5.71e-05	0.000432	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GPR65—multiple sclerosis	5.65e-05	0.000427	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—multiple sclerosis	5.62e-05	0.000425	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CNR1—multiple sclerosis	5.46e-05	0.000413	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCR5—multiple sclerosis	5.44e-05	0.000412	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SRM—multiple sclerosis	5.44e-05	0.000411	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.42e-05	0.00041	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—multiple sclerosis	5.37e-05	0.000406	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—multiple sclerosis	5.34e-05	0.000404	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—RRM1—multiple sclerosis	5.33e-05	0.000403	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-A—multiple sclerosis	5.33e-05	0.000403	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—multiple sclerosis	5.32e-05	0.000402	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HLA-A—multiple sclerosis	5.31e-05	0.000401	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—multiple sclerosis	5.29e-05	0.0004	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.28e-05	0.000399	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD28—multiple sclerosis	5.24e-05	0.000396	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—STAT3—multiple sclerosis	5.17e-05	0.000391	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL13—multiple sclerosis	5.16e-05	0.00039	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR1—multiple sclerosis	5.16e-05	0.00039	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTPRC—multiple sclerosis	5.15e-05	0.000389	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CCR2—multiple sclerosis	5.15e-05	0.000389	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SRM—multiple sclerosis	5.13e-05	0.000388	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	5.08e-05	0.000384	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	5.08e-05	0.000384	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—multiple sclerosis	5.08e-05	0.000384	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.06e-05	0.000383	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—multiple sclerosis	4.98e-05	0.000376	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	4.98e-05	0.000376	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—multiple sclerosis	4.98e-05	0.000376	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DPB1—multiple sclerosis	4.97e-05	0.000376	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APOE—multiple sclerosis	4.95e-05	0.000374	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—multiple sclerosis	4.93e-05	0.000373	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL10—multiple sclerosis	4.92e-05	0.000372	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—multiple sclerosis	4.89e-05	0.00037	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DRB1—multiple sclerosis	4.87e-05	0.000368	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—multiple sclerosis	4.87e-05	0.000368	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—STAT3—multiple sclerosis	4.85e-05	0.000367	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD28—multiple sclerosis	4.84e-05	0.000366	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ITGA4—multiple sclerosis	4.78e-05	0.000362	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40—multiple sclerosis	4.78e-05	0.000362	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.75e-05	0.000359	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNB1—multiple sclerosis	4.75e-05	0.000359	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTLA4—multiple sclerosis	4.72e-05	0.000356	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—MAPK1—multiple sclerosis	4.7e-05	0.000356	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD80—multiple sclerosis	4.68e-05	0.000354	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ICAM1—multiple sclerosis	4.67e-05	0.000353	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.66e-05	0.000353	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.65e-05	0.000351	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD80—multiple sclerosis	4.5e-05	0.00034	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD80—multiple sclerosis	4.48e-05	0.000338	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—MAPK1—multiple sclerosis	4.41e-05	0.000334	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	4.41e-05	0.000333	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD86—multiple sclerosis	4.3e-05	0.000325	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL5—multiple sclerosis	4.23e-05	0.00032	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—VCAM1—multiple sclerosis	4.16e-05	0.000315	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQA1—multiple sclerosis	4.15e-05	0.000314	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TYK2—multiple sclerosis	3.95e-05	0.000299	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SPP1—multiple sclerosis	3.92e-05	0.000296	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQB1—multiple sclerosis	3.88e-05	0.000294	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.85e-05	0.000291	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.84e-05	0.00029	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.84e-05	0.00029	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR5—multiple sclerosis	3.81e-05	0.000288	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TYK2—multiple sclerosis	3.78e-05	0.000286	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2RA—multiple sclerosis	3.76e-05	0.000284	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD86—multiple sclerosis	3.74e-05	0.000283	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL3—multiple sclerosis	3.68e-05	0.000278	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—multiple sclerosis	3.67e-05	0.000277	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—multiple sclerosis	3.63e-05	0.000274	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—multiple sclerosis	3.61e-05	0.000273	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.61e-05	0.000273	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.61e-05	0.000273	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—multiple sclerosis	3.58e-05	0.00027	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTGER4—multiple sclerosis	3.54e-05	0.000268	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPC5—multiple sclerosis	3.51e-05	0.000265	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-B—multiple sclerosis	3.49e-05	0.000264	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PGR—multiple sclerosis	3.49e-05	0.000264	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APOE—multiple sclerosis	3.47e-05	0.000262	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD86—multiple sclerosis	3.45e-05	0.000261	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—multiple sclerosis	3.43e-05	0.00026	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR3—multiple sclerosis	3.42e-05	0.000259	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—multiple sclerosis	3.42e-05	0.000258	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—multiple sclerosis	3.39e-05	0.000256	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD28—multiple sclerosis	3.39e-05	0.000256	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SRM—multiple sclerosis	3.35e-05	0.000254	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR2—multiple sclerosis	3.33e-05	0.000252	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.31e-05	0.00025	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2RA—multiple sclerosis	3.27e-05	0.000247	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-A—multiple sclerosis	3.23e-05	0.000244	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD80—multiple sclerosis	3.14e-05	0.000237	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.11e-05	0.000235	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CNR1—multiple sclerosis	3.07e-05	0.000232	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—multiple sclerosis	3.06e-05	0.000231	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—BCHE—multiple sclerosis	3.06e-05	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HLA-A—multiple sclerosis	2.98e-05	0.000226	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—POMC—multiple sclerosis	2.98e-05	0.000225	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—multiple sclerosis	2.96e-05	0.000223	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DRB1—multiple sclerosis	2.95e-05	0.000223	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL2—multiple sclerosis	2.92e-05	0.00022	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—RRM1—multiple sclerosis	2.91e-05	0.00022	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ICAM1—multiple sclerosis	2.83e-05	0.000214	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOE—multiple sclerosis	2.79e-05	0.000211	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL10—multiple sclerosis	2.76e-05	0.000209	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.74e-05	0.000207	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD80—multiple sclerosis	2.73e-05	0.000206	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.68e-05	0.000203	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.68e-05	0.000202	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TYK2—multiple sclerosis	2.65e-05	0.0002	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—multiple sclerosis	2.65e-05	0.0002	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.62e-05	0.000198	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD80—multiple sclerosis	2.52e-05	0.00019	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MAPK1—multiple sclerosis	2.52e-05	0.00019	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.5e-05	0.000189	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—multiple sclerosis	2.46e-05	0.000186	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—multiple sclerosis	2.45e-05	0.000185	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD86—multiple sclerosis	2.42e-05	0.000183	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MAPK1—multiple sclerosis	2.41e-05	0.000182	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL5—multiple sclerosis	2.38e-05	0.00018	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.36e-05	0.000179	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.36e-05	0.000179	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TYK2—multiple sclerosis	2.3e-05	0.000174	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.21e-05	0.000167	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPP1—multiple sclerosis	2.2e-05	0.000167	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—multiple sclerosis	2.2e-05	0.000166	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.16e-05	0.000163	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—multiple sclerosis	2.16e-05	0.000163	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—multiple sclerosis	2.14e-05	0.000162	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TYK2—multiple sclerosis	2.13e-05	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2RA—multiple sclerosis	2.11e-05	0.00016	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—multiple sclerosis	2.08e-05	0.000158	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—multiple sclerosis	2.08e-05	0.000157	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—multiple sclerosis	1.95e-05	0.000147	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—multiple sclerosis	1.93e-05	0.000146	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—multiple sclerosis	1.92e-05	0.000145	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—multiple sclerosis	1.92e-05	0.000145	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—multiple sclerosis	1.92e-05	0.000145	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—multiple sclerosis	1.85e-05	0.00014	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—multiple sclerosis	1.85e-05	0.00014	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—multiple sclerosis	1.84e-05	0.000139	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.79e-05	0.000135	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD80—multiple sclerosis	1.76e-05	0.000133	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—multiple sclerosis	1.72e-05	0.00013	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—multiple sclerosis	1.72e-05	0.00013	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAPK1—multiple sclerosis	1.69e-05	0.000127	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.68e-05	0.000127	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—POMC—multiple sclerosis	1.68e-05	0.000127	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—BCHE—multiple sclerosis	1.67e-05	0.000126	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—multiple sclerosis	1.64e-05	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—multiple sclerosis	1.61e-05	0.000122	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—POMC—multiple sclerosis	1.58e-05	0.00012	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.57e-05	0.000119	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TYK2—multiple sclerosis	1.49e-05	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—multiple sclerosis	1.49e-05	0.000113	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MAPK1—multiple sclerosis	1.47e-05	0.000111	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—multiple sclerosis	1.44e-05	0.000109	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—multiple sclerosis	1.38e-05	0.000105	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—multiple sclerosis	1.38e-05	0.000104	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAPK1—multiple sclerosis	1.35e-05	0.000102	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—multiple sclerosis	1.33e-05	0.000101	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—multiple sclerosis	1.29e-05	9.79e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—multiple sclerosis	1.24e-05	9.36e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—multiple sclerosis	1.17e-05	8.86e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—POMC—multiple sclerosis	1.14e-05	8.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—multiple sclerosis	1.13e-05	8.51e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—multiple sclerosis	1.04e-05	7.88e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—multiple sclerosis	1.04e-05	7.88e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—multiple sclerosis	1.04e-05	7.86e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.03e-05	7.77e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—multiple sclerosis	1e-05	7.59e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—multiple sclerosis	9.69e-06	7.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—multiple sclerosis	9.66e-06	7.3e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAPK1—multiple sclerosis	9.48e-06	7.16e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—multiple sclerosis	9.46e-06	7.15e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—POMC—multiple sclerosis	8.63e-06	6.52e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—POMC—multiple sclerosis	8.13e-06	6.15e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—multiple sclerosis	7.87e-06	5.95e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—multiple sclerosis	7.41e-06	5.6e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—multiple sclerosis	7.28e-06	5.5e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—multiple sclerosis	6.19e-06	4.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—POMC—multiple sclerosis	5.32e-06	4.02e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—multiple sclerosis	4.85e-06	3.66e-05	CbGpPWpGaD
